TANDEM DIABETES CARE INC (TNDM)
Health Care · Insulin pump / automated insulin delivery devices · NASDAQ
Tandem designs intelligent, consumer-friendly insulin pumps with automated closed-loop technology to help people with insulin-dependent diabetes manage their condition with greater flexibility and less burden.
What TANDEM DIABETES CARE INC does
Tandem Diabetes Care designs, develops, and commercializes insulin delivery systems and diabetes management technology for people with insulin-dependent diabetes. The company serves nearly 500,000 patients across more than 25 countries, offering durable insulin pumps with automated insulin delivery (AID) algorithms and continuous glucose monitoring integration. Its flagship products include the t:slim X2 and Tandem Mobi pumps, both featuring Control-IQ+ advanced hybrid closed-loop technology.
Themes: ["insulin delivery / diabetes management","automated insulin delivery (AID)","Type 1 diabetes","Type 2 diabetes / insulin therapy","continuous glucose monitoring"]
Fundamentals
- Price$15.37 as of 2026-07-09 close
- Market cap$1.0B as of 2026-07-10
- 1-year return-3.0% as of 2026-07-09 close
- Net margin-9.2% as of 2026-07-10
- Gross margin+54.9% as of 2026-07-10
- ROE-68.3% as of 2026-07-10
- Debt / equity4.58 as of 2026-07-10
- Revenue growth (YoY)+4.5% as of 2026-07-10
- Revenue CAGR (3y)+8.2% SEC XBRL
- Beta1.55 as of 2026-07-10
Key risks (from latest filing)
["Insulin pump market remains underpenetrated (40% of Type 1 and 5% of Type 2 diabetics use pump therapy in the US), limiting growth opportunities","Company is currently unprofitable with negative net margin of -9.2%, and faces significant dependency on successfully commercializing new products like Mobi","Regulatory and reimbursement pressures in multiple geographic markets (25+ countries) affect pricing, market access, and product approvals"]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.